254 related articles for article (PubMed ID: 3757467)
1. [Circadian profiles of lactic and pyruvic acid in diabetic patients treated with biguanides and sulfonylureas].
Cheli V; Buzzo P; Melga P; Accoto S; Prando R
Clin Ter; 1986 Aug; 118(4):269-75. PubMed ID: 3757467
[No Abstract] [Full Text] [Related]
2. [Effects of some oral hypoglycemia drugs on blood levels of lactic and pyruvic acid in diabetes mellitus].
Sgambato S; Bisesti V; Giugliano D; Passariello N; Saccomanno F
Clin Ter; 1980 Apr; 93(2):183-92. PubMed ID: 7449337
[No Abstract] [Full Text] [Related]
3. [Alteration of blood lactic acid levels in biguanide therapy in diabetics].
Yang DP; Liang JZ; Luo ZT
Sichuan Yi Xue Yuan Xue Bao; 1985 Jun; 16(2):162-5. PubMed ID: 3939266
[No Abstract] [Full Text] [Related]
4. [Effect of biguanides on the indicators of thrombelastography and the level of lactic acid in diabetes mellitus].
Blagosklonnaia IaV; Krasil'nikova EI; Zaĭed N; Babenko AIu
Sov Med; 1990; (12):17-20. PubMed ID: 2097752
[TBL] [Abstract][Full Text] [Related]
5. Non-insulin-dependent diabetes: 10-year outcome in relation to initial response to diet and subsequent sulfonylurea therapy.
Sönksen PH; Lowy C; Perkins JR; Lim HS
Diabetes Care; 1984; 7 Suppl 1():59-66. PubMed ID: 6376030
[TBL] [Abstract][Full Text] [Related]
6. [Comparative activity of some biguanides, sulfonylureas and their combinations on blood sugar and lactic acid in the guinea pig. II].
Bramanti G; Bianchini P; De Fina V; Dell'Omodarme G
Boll Chim Farm; 1971 Apr; 110(4):226-36. PubMed ID: 5111348
[No Abstract] [Full Text] [Related]
7. All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides.
Mannucci E; Monami M; Masotti G; Marchionni N
Diabetes Metab Res Rev; 2004; 20(1):44-7. PubMed ID: 14737744
[TBL] [Abstract][Full Text] [Related]
8. [Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II].
Lunetta M; Presti C; Mughini MT; Mughini L
Clin Ter; 1980 Jun; 93(6):657-72. PubMed ID: 6775864
[No Abstract] [Full Text] [Related]
9. Alcohol tolerance in patients with non-insulin-dependent (type 2) diabetes treated with sulphonylurea derivatives.
Lao B; Czyzyk A; Szutowski M; Szczepanik Z
Arzneimittelforschung; 1994 Jun; 44(6):727-34. PubMed ID: 8053971
[TBL] [Abstract][Full Text] [Related]
10. Editorial: Oral therapy in diabetes mellitus.
Scoville AB
South Med J; 1974 Jun; 67(6):635-8. PubMed ID: 4208385
[No Abstract] [Full Text] [Related]
11. [Glucose, lactic acid and pyruvic acid levels of the blood and cerebrospinal fluid in patients with diabetes mellitus and cerebral infarction].
Kawiak W; Stelmasiak Z; Nowicki J; Hasiec T; Gieracz-Nazar A; Wróblewski L
Wiad Lek; 1987 Jul; 40(14):968-74. PubMed ID: 3433766
[No Abstract] [Full Text] [Related]
12. Blood lactate and pyruvate levels in diabetic patient treated with sulphonylureas with and without biguanides.
Sitprija S; Vajanamarhutue C; Bunnag S
J Med Assoc Thai; 1982 Feb; 65(2):63-71. PubMed ID: 7077214
[No Abstract] [Full Text] [Related]
13. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
Harrigan RA; Nathan MS; Beattie P
Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
[TBL] [Abstract][Full Text] [Related]
14. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
Fövényi J
Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874
[No Abstract] [Full Text] [Related]
15. Management of diabetes.
Tripathy BB; Samal KC
J Assoc Physicians India; 1983 Apr; 31(4):235-40. PubMed ID: 6358183
[No Abstract] [Full Text] [Related]
16. Effects of pyridoxine alpha-ketoglutarate on blood glucose and lactate in type I and II diabetics.
Passariello N; Fici F; Giugliano D; Ceriello A; Dello Russo P; Sgambato S
Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):252-6. PubMed ID: 6862730
[No Abstract] [Full Text] [Related]
17. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients.
Tseng CH; Huang TS
Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579
[No Abstract] [Full Text] [Related]
18. [Chronic kidney disease and antidiabetic treatment].
Berwert L; Teta D; Zanchi A
Rev Med Suisse; 2007 Mar; 3(101):598-604. PubMed ID: 17436798
[TBL] [Abstract][Full Text] [Related]
19. Oral hypoglycemic agents in type II diabetes mellitus.
Lubbos H; Miller JL; Rose LI
Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
[TBL] [Abstract][Full Text] [Related]
20. [Serum concentration of lactate in diabetic patients treated with biguanides in relationship to renal function (author's transl)].
Sailer D; Ganawal S; Berg G
Med Klin; 1979 Mar; 74(9):318-24. PubMed ID: 423858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
